Treatment Outcomes of 257 Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Nimotuzumab Plus Intensity-Modulated Radiotherapy with or without Chemotherapy: A Single-Institution Experience.
Transl Oncol
; 11(1): 65-73, 2018 Feb.
Article
in En
| MEDLINE
| ID: mdl-29202278
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Transl Oncol
Year:
2018
Document type:
Article
Country of publication:
United States